Document:

csi8k10_2.htm

THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE WITH THE REQUIREMENTS OF SUCH ACT
AND THE APPLICABLE SECURITIES LAW OF ANY STATE OR OTHER JURISDICTION.

WARRANT TO PURCHASE [NUMBER OF SHARES] SHARES

OF THE COMMON STOCK OF

COPSYNC, INC.

Warrant No.: 2009-B[____]                                                                                                Date
of Issuance: October 14, 2009

This certifies that [_________] or his, her or its permitted assigns (each individually, a “Holder”) for value received, shall be entitled to purchase from COPsync, Inc., a Delaware corporation
(the “Company”), having its principal place of business at 2010 FM 2673, Canyon Lake, Texas 78133, a maximum of [_______] fully paid and nonassessable shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), for a purchase price equal to $0.20 per share (the “Exercise
Price”) at any time, or from time to time, up to and including 5:00 p.m., Central Standard time on the date two years after the date of issuance of this Warrant (the “Expiration Date”), upon (i) the surrender to the Company at its principal place of business (or at such other location as the Company may advise the Holder in writing) of this Warrant and a Form of Subscription in substantially the form attached
hereto duly completed and executed and, (ii) payment in cash or by check or other consideration permitted pursuant to Section 1(b) hereof of the aggregate Exercise Price for the number of shares for which this Warrant is being exercised, determined in accordance with the provisions hereof.  The Exercise Price and the number of shares of Common Stock purchasable hereunder are subject to adjustment as provided in Section 3 hereof.

This Warrant is one of a series of Warrants issued for shares of Common Stock of the Company pursuant to that certain Securities Purchase Agreement, dated October 14, 2009, by and among the Company and various purchasers (collectively, the “Warrant Series”).

This Warrant is subject to the following terms and conditions:

1.           Exercise; Issuance of Certificates; Payment For Shares.

(a)           General.  This Warrant is exercisable at the option of the Holder of record hereof, at any time or from time to time up to the Expiration Date for all or any part of the shares of Common Stock
(but not for a fraction of a share) which may be purchased hereunder.  The Company agrees that the shares of Common Stock purchased under this Warrant shall be and are deemed to be issued to the Holder hereof as the record owner of such shares as of the close of business on the date on which (i) this Warrant shall have been surrendered, properly endorsed, (ii) the completed, executed Form of Subscription shall have been surrendered, and (iii) payment shall have been made to the Company for such shares,
in each case, at the Company’s address set forth above (or at such other location as the Company may advise the Holder in writing).  Certificates for the shares of Common Stock so purchased, together with any other securities or property to which the Holder is entitled upon such exercise, shall be delivered to the Holder by the Company at the Company’s expense within a reasonable time after the rights represented by this Warrant have been so exercised, and in any event, within ten (10) days
of such exercise.  In case of a purchase of less than all the shares that may be purchased under this Warrant, the Company shall cancel this Warrant and execute and deliver a new Warrant or Warrants of like tenor for the balance of the shares purchasable under the Warrant surrendered upon such purchase, to the Holder hereof within a reasonable time.  Each stock certificate so delivered shall be in such denominations
of Common Stock as may be requested by the Holder hereof and shall be registered in the name of the Holder.

COPsync Series B Form of Warrant

 

  

1

  

(b)           Common Stock Legend.  Upon any exercise of the Warrants, certificates representing the shares of Common Stock shall bear a restrictive legend substantially identical to that set forth on the face
of this Warrant.

2.           Shares To Be Fully Paid; Reservation of Shares.

The Company covenants and agrees that all shares of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will, upon issuance, be duty authorized, validly issued, fully paid and nonassessable and free of all taxes, liens and charges with respect to the issue thereof.  The Company further
covenants and agrees that, during the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized and reserved, for the purpose of issue or transfer upon exercise of the subscription rights evidenced by this Warrant, a sufficient number of shares of authorized but unissued Common Stock, or other securities and property, when and as required to provide for the exercise of the rights represented by this Warrant.  The Company will take all
such action as may be necessary to assure that such shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of any domestic securities exchange upon which the Common Stock may be listed; provided, however, that the Company shall not be required to effect a registration under Federal or State securities laws
with respect to such exercise, except as described in Section 4.

3.           Adjustment of Exercise Price and Number of Shares.

The Exercise Price and the number of shares (or amount of other securities or property) purchasable upon the exercise of this Warrant shall be subject to adjustment from time to time upon the occurrence of certain events described in this Section 3.  This Section
shall not require an adjustment to the Exercise Price in connection with any dividends paid in cash or upon any sale of shares of Common Stock for a per share price that is less than the Exercise Price.

(a)           Subdivision or Combination of Stock.     If the Company shall effect a stock dividend or stock split or subdivide its outstanding shares of Common Stock into a greater number of
shares, the Exercise Price in effect immediately prior to such stock dividend, stock split or subdivision shall be proportionately reduced, and conversely, if the Company shall effect a reverse stock split or combine its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such reverse stock split or combination shall be proportionately increased.  Upon each adjustment of the Exercise Price, the Holder of this Warrant shall thereafter
be entitled to purchase, at the Exercise Price resulting from such adjustment, the number of shares obtained by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of shares purchasable pursuant hereto immediately prior to such adjustment, and dividing the product thereof by the Exercise Price resulting from such adjustment.

(b)           Dividends in Common Stock, Other Stock, Property, Reclassification.     If the holders of Common Stock (or any shares of stock or other securities at the time receivable upon the
exercise of this Warrant) shall have received or become entitled to receive, without payment therefor,

(i)           Common Stock or any shares of stock or other securities that are directly or indirectly convertible into or exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend or other distribution
(other than shares of Common Stock issued as a stock dividend, stock split or subdivision, adjustments in respect of which shall be covered by the terms of Section 3(a) above),

COPsync Series B Form of Warrant

 

  

2

  

(ii)           any cash paid or payable otherwise than as a cash dividend (other than a liquidation or dissolution, which shall be covered by the terms of Section 3(d) below), or

(iii)           additional shares of Common Stock or additional stock or other securities or property (including cash) by way of spin-off, split-up, reclassification, recapitalization, reorganization, combination of shares or similar corporate rearrangement (other than shares of Common
Stock issued as a stock dividend, stock split or subdivision, adjustments in respect of which shall be covered by the terms of Section 3(a) above),

then, and in each such case, the Holder hereof shall, upon the exercise of this Warrant, be entitled to receive, in addition to the number of shares of Common Stock receivable upon such exercise, and without payment of any additional consideration therefor, the amount of stock and other securities and property (including
cash in the cases referred to in clauses (ii) and (iii) above) which such Holder would hold on the date of such exercise had such Holder been the holder of record of such Common Stock as of the date on which holders of Common Stock received or became entitled to receive such shares or all other additional stock and other securities and property.

(c)           Reorganization, Reclassification, Consolidation, Merger or Sale.  If any reclassification, recapitalization or reorganization, or consolidation or merger of the Company with another entity, or
the sale of all or substantially all of its assets or other similar transaction, shall be effected in such a way that holders of Common Stock shall be entitled to receive, with respect to or in exchange for their shares of Common Stock, securities or other assets or property (an “Organic Change”) and the Company is the resulting or surviving corporation of such Organic Change, then, as a condition of such Organic Change, provisions
shall be made by the Company whereby the Holder hereof shall thereafter have the right to purchase and receive (in lieu of the shares of the Common Stock of the Company purchasable and receivable upon the exercise of this Warrant immediately prior to such Organic Change) such shares of stock, securities or other assets or property as may be issued or payable in connection with such Organic Change with respect to or in exchange for the number of outstanding shares of such Common Stock purchasable and receivable
upon the exercise of this Warrant immediately prior to such Organic Change.  In the event of any Organic Change, appropriate provision shall be made by the Company with respect to the rights and interests of the Holder of this Warrant to the end that the provisions hereof (including, without limitation, provisions for adjustments of the Exercise Price and of the number of shares (or amount of stock, other securities or property) purchasable and receivable upon the exercise of this Warrant) shall thereafter
be applicable, in relation to any shares of stock, securities or property thereafter deliverable upon the exercise hereof.  In the event of any Organic Change pursuant to which the Company is not the surviving or resulting corporation, prior to the consummation thereof, the corporation resulting from such Organic Change or the corporation purchasing such assets shall assume by written instrument the obligation to deliver to the Holder such shares of stock, securities or assets as, in accordance with
the foregoing provisions, the Holder may be entitled to purchase; provided, however, this Warrant may be canceled by the Company as of the effective date of any such Organic Change pursuant to which the Company is not the surviving or resulting entity, and in which the holders of the voting securities of the Company outstanding immediately prior to such transaction do not retain, immediately
after such Organic Change, at least a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity,  by giving notice to the Holder of the Company’s intent to do so at least thirty (30) business days prior to the effective date of such Organic Change or record date associated with such Organic Change, whichever is earlier.

COPsync Series B Form of Warrant

 

  

3

  

(d)           Liquidation or Dissolution.  In the event of a proposed dissolution or liquidation of the Company, this Warrant will terminate immediately prior to the consummation of such proposed action, so
long as the Company has delivered the notice required by Section 3(f)(iv) below, giving the Holder the opportunity to exercise this Warrant prior to such dissolution or liquidation.

(e)           Certain Events.  If any change in the outstanding Common Stock of the Company or any other event occurs as to which the other provisions of this Section
3 are not strictly applicable or if strictly applicable would not fairly protect the purchase rights of the Holder of the Warrant in accordance with such provisions, then the Board of Directors of the Company shall make an adjustment in the number and class of shares or other securities or property available under the Warrant, the Exercise Price or the application of such provisions, so as to protect such purchase rights as aforesaid. The adjustment shall be such as will give the Holder of the Warrant
upon exercise for the same aggregate Exercise Price the total number, class and kind of shares or other securities or property as the Holder have owned had the Warrant been exercised prior to the event and had the Holder continued to hold such shares until after the event requiring adjustment.

(f)           Notices of Change.

(i)           Immediately upon any adjustment in the number or class of shares subject to this Warrant and of the Exercise Price, the Company shall give written notice thereof to the Holder, setting forth in reasonable detail and certifying the calculation of such adjustment,

(ii)           The Company shall give written notice to the Holder at least thirty (30) business days prior to the date on which the Company closes its books or takes a record for determining rights to receive any dividends or distributions,

(iii)           The Company shall also give written notice to the Holder at least thirty (30) business days prior to the date on which an Organic Change shall take place, and

(iv)           The Company shall give written notice to the Holder at least thirty (30) business days prior to the effective date of any proposed liquidation or dissolution of the Company.

(g)           Calculations.  All calculations under this Section 3 shall be made to the nearest
cent or the nearest 1/100th of a share, as applicable.  The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.

(h)           Adjustments.  Notwithstanding any provision of this Section 3, no adjustment of
the Exercise Price shall be required if such adjustment is less than $0.01; provided, however, that any adjustments that by reason of this Section 3(h) are not required to be made shall be carried forward and taken into account for purposes of any subsequent adjustment.

4.           Registration Rights.

Shares of Common Stock issued upon exercise of this Warrant shall be registrable and subject to the terms of that certain Investors’ Rights Agreement dated as of date hereof by and among the Company and various purchasers, by which the Company has agreed to file a registration statement for the resale of the shares of Common Stock.

5.           Issue Tax.

COPsync Series B Form of Warrant

 

  

4

  

The issuance of certificates for shares of Common Stock upon the exercise of the Warrant shall be made without charge to the Holder of the Warrant for any issue tax (other than any applicable income taxes) in respect thereof; provided, however,
that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate in a name other than that of the then Holder of the Warrant being exercised.

6.           No Voting or Dividend Rights; Limitation of Liability.

Nothing contained in this Warrant shall be construed as conferring upon the Holder hereof the right to vote or to consent or to receive notice as a stockholder of the Company or any other matters or any rights whatsoever as a stockholder of the Company, solely by virtue of being the Holder of this Warrant.  No dividends or interest
shall be payable or accrue in respect of this Warrant or the interest represented hereby or the shares purchasable hereunder until, and only to the extent that, this Warrant shall have been exercised. No provisions hereof, in the absence of affirmative action by the Holder to purchase shares of Common Stock, and no mere enumeration herein of the rights or privileges of the Holder hereof shall give rise to any liability of such Holder for the Exercise Price or as a stockholder of the Company, whether such liability
is asserted by the Company or by its creditors.

7.           Transfer; Division and Combination.

(a)           Transfer Restricted.  This Warrant, and any rights hereunder, may not be assigned or transferred, except as provided in the legend hereon and in accordance with and subject to provisions of (i)
all applicable state securities laws, and (ii) the Securities Act, and the rules and regulations promulgated thereunder.  Any purported transfer or assignment made other than in accordance with this Section 7 shall be null and void and of no force and effect.

(b)           Assignment.  Any assignment permitted hereunder shall be made by surrender of this Warrant to the Company at its principal place of business as set forth above with a Form of Assignment in substantially
the form attached hereto duly completed and executed and funds sufficient to pay any transfer tax, if any.  In such event, the Company shall, without charge, execute and deliver a new Warrant in the name of the assignee named in such instrument of assignment in the amount so assigned and this Warrant shall be promptly canceled; provided, however, that in the event that Holder
hereof shall assign or transfer less thank the full amount of this Warrant, a new Warrant evidencing the remaining portion of this Warrant not so assigned or transferred shall be issued in the name of the Holder.

(c)           Division and Combination.  This Warrant may divided or combined with other Warrants upon presentation and surrender hereof at the principal place of business of the Company as set forth above,
together with a written notice specifying the names and denominations in which new Warrants are to be issued signed by the Holder.  Subject to compliance with Section 3(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants of like tenor in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.

(d)           Non-Interference; Par Value.  The Company shall not close its books against the transfer of this Warrant or any share of Common stock issued or issuable upon the exercise of this Warrant in any
manner which interferes with the timely exercise of this Warrant.  The Company shall from time to time take all such action as may be necessary to ensure that the par value per share of the unissued Common Stock acquirable upon exercisable of this Warrant is at all times equal to or less than the Exercise Price then in effect.

COPsync Series B Form of Warrant

 

  

5

  

8.           Register.

The Company will maintain a register containing the names and addresses of the registered Holders of the Warrant Series.  The Holder may change his or its address as shown on the Warrant register at any time by giving written notice to the Company requesting such change.

9.           Fractional Shares.

No fractional shares shall be issued upon exercise of this Warrant.  The Company shall, in lieu of issuing any fractional share, pay the Holder entitled to such fraction a sum in cash equal to such fraction multiplied by the then effective Exercise Price.

10.           Miscellaneous.

(a)           Amendments.     Any term of this Warrant may be amended with the written consent of the Company and the Holders of Warrants constituting the Warrant Series representing not less
than a majority of the shares of Common Stock issuable upon exercise of any and all outstanding Warrants constituting the Warrant Series, even without the consent of the Holder.  Any amendment effected in accordance with this Section 10(a) shall be binding upon each Holder of any of the Warrants constituting the Warrant Series, each future Holder of all such Warrants, and the Company; provided, however,
that no special consideration or inducement may be given to any such Holder in connection with such consent that is not given ratably to all such Holders, and that such amendment must apply to all such Holders equally and ratably in accordance with the number of shares of Common Stock issuable upon exercise of their Warrants.  The Company shall promptly give notice to all Holders of the Warrants constituting the Warrant Series of any amendment effected in accordance with this Section
10(a).

(b)           Notices.  Any notice, request or other document required or permitted to be given or delivered to the Holder hereof or the Company
shall be delivered or shall be sent by certified mail, postage prepaid, to each such Holder at its address as on the Warrant Register or to the Company at the address indicated therefor in the first paragraph of this Warrant or such other address as either may from time to time provide to the other.

(c)           Binding Effect on Successors.  This Warrant shall be binding upon any corporation succeeding the Company by merger, consolidation
or acquisition of all or substantially all of the Company’s assets.  All of the covenants and agreements of the Company shall inure to the benefit of the permitted successors and assigns of the Holder hereof.

(d)           Descriptive Headings and Governing Law.  The descriptive headings of the several sections and paragraphs of this Warrant are inserted
for convenience only and do not constitute a part of this Warrant. This Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the State of Delaware.

(e)           Lost Warrants.  The Company represents and warrants to the Holder hereof that upon receipt of evidence reasonably satisfactory to
the Company of the loss, theft, destruction, or mutilation of this Warrant and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to the Company, or, in the case of any such mutilation, upon surrender and cancellation of such Warrant, the Company, at its expense, will make and deliver a new Warrant, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant.

[REMAINDER OF PAGE INTENTIONALLY BLANK]

COPsync Series B Form of Warrant

 

  

6

  

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date of issuance written above.

COMPANY:

COPSYNC, INC.

By:                                                                                                                                                     

Name:                                                                                                                                                

Title:                                                                                                                                                

COPsync Series B Form of Warrant

 

  

7

  

EXHIBIT A

FORM OF SUBSCRIPTION

Date:  ____________, 200_

COPsync, Inc.

2010 FM 2673

Canyon Lake, Texas  78133

Attn: Chief Executive Officer

Ladies and Gentlemen:

The undersigned hereby elects to exercise the warrant issued to it by COPsync, Inc. (the “Company’) and dated October 14, 2009 (the “Warrant”) and to purchase thereunder  ________
shares of the Common Stock of the Company (the “Shares”) at a purchase price of $0.20 per Share for an aggregate purchase price of ______________Dollars ($               ) (the “Exercise Price”).  Pursuant
to the terms of the Warrant, the undersigned has delivered the Exercise Price herewith in full in cash or by certified check or wire transfer.

In connection with the exercise of the Warrant to purchase the number of shares specified above, undersigned makes the following representations and covenants:

1.           The undersigned is an “Accredited Investor,” as such term is defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities
Act”).

2.           The undersigned is purchasing the Shares for the undersigned’s own account, or for one or more investor accounts for which the undersigned is acting as a fiduciary or agent, in each case for investment, and not with
a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act.

3.           The undersigned has had access to such financial and other information concerning the Company and the Shares that the undersigned has deemed necessary in connection with a decision to purchase the Shares, including an opportunity
to ask questions of and request information from the Company.

Very truly yours,

	
By:                                                                                      
	 

 

	
Name:                                                                                      

 

Title:                                                                                      
	 

                                                       

COPsync Series B Form of Warrant

  

  

  

EXHIBIT B

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute this form and supply required information.

Do not use this form to exercise the Warrant)

                  FOR VALUE RECEIVED,                                                                                                                           hereby
sells,  assigns and transfers all of the rights of the undersigned  under the attached  Warrant (No. 2009- _____) with respect to the number of shares of Common Stock covered thereby set forth below, unto:

Name of Assignee                                                                    Address                                         No.
of Shares

By:                                                                    

Name:                                                               

Title:                                                               

Signature Guaranteed:

By:                                                                    

The signature should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program) pursuant to Rule 17Ad-15 under the Securities Exchange Act of 1934.

COPsync Series B Form of Warrantcsi8k10_3.htm

 

COPSYNC, INC.

 

INVESTORS’ RIGHTS AGREEMENT

 

October 14, 2009

 

  

  

  

 

	 	 TABLE OF CONTENTS	 
	 	 	 Page
	 	 	 
	 Section 1  Definitions	 1
	 1.1	 Certain Definitions	 1
	 	 	 
	 Section 2   Registration Rights	 3
	 2.1	 Requested Registration 	 3
	 2.2	 Company Registration	 4
	 2.3	 Expenses of Registration	 5
	 2.4	 Registration Procedures	 6
	 2.5	 Indemnification	 7
	 2.6	 Information by Holder	 9
	 2.7	 Restrictions on Transfer	 9
	 2.8	 Rule 144 Reporting	 10
	 2.9	 Delay of Registration	 10
	 2.10	 Transfer or Assignment of Registration Rights	 11
	 2.11	 Termination of Registration Rights	 11
	 	 	 
	 Section 3   Right of First Refusal	 11
	 3.1	 Right of First Refusal	 11
	 3.2	 Termination of Right of First Refusal	 12
	 	 	 
	 Section 4   Additional Covenants	 12
	 4.1	 Matters Requiring Board Approval	 12
	 4.2	 Monthly Board Meetings	 12
	 4.3	 Board Expenses and Indemnification	 12
	 4.4	 Patents Rights	 12
	 4.5	 Termination of Additioanl Covenants	 13
	 	 	 
	 Section 5   Miscellaneous	 13
	 5.1	 Amendment	 13
	 5.2	 Notices	 13
	 5.3	 Governing Law	 14
	 5.4	 Successors and Assigns	 14
	 5.5	 Entire Agreement	 14
	 5.6	 Delays or Omissions	 15
	 5.7	 Severability	 15
	 5.8	 Title and Subtitles	 15
	 5.9	 Counterparts	 15
	 5.10	 Telecopy Execution and Delivery	 15
	 5.11	 Jurisdiction; Venue	 15
	 5.12	 Further Assurances	 16
	 5.13	 Termination Upon Change of Control	 16
	 5.14	 Conflict	 16
	 5.15	 Aggregate of Stock	 16

 

 

  

i

  

 

COPSYNC, INC.

INVESTORS’ RIGHTS AGREEMENT

 

 

This Investors’ Rights Agreement (this “Agreement”) is made as of October 14, 2009, by and among COPsync, Inc., a Delaware corporation (the “Company”), and the persons and entities (each, an “Investor”
and collectively, the “Investors”) listed on Exhibit A hereto.  Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.

 

RECITALS

 

WHEREAS: The Investors and the Company are parties to the Securities Purchase Agreement of even date herewith (the “Purchase Agreement”), and it is a condition to the closing of the sale of the Series B Preferred
Stock and warrants to purchase Common Stock to the Investors under the Purchase Agreement that the Investors and the Company execute and deliver this Agreement.

 

NOW, THEREFORE: In consideration of the mutual promises and covenants set forth herein, and other consideration, the receipt and adequacy of which is hereby acknowledged, the parties hereto agree as follows:

 

Section 1

 

Definitions

 

1.1      Certain Definitions

 

.  As used in this Agreement, the following terms shall have the meanings set forth below:

 

(a)      “Commission” means the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.

 

(b)           “Common Stock” means the Common Stock of the Company.

 

(c)      “Conversion Stock” means shares of Common Stock issued upon conversion of the Series B Preferred Stock.

 

(d)      “Exchange Act” means the Securities Exchange Act of 1934, as amended, or any similar successor federal statute and the rules and regulations thereunder, all as the same shall be in effect from time to time.

 

(e)      “Holder” means any Investor who holds Registrable Securities and any holder of Registrable Securities to whom the registration rights conferred by this Agreement have been duly and validly transferred in accordance with Section 2.10 of
this Agreement.

 

(f)      “Indemnified Party” shall have the meaning set forth in Section 2.5(c) hereto.

 

(g)      “Indemnifying Party” shall have the meaning set forth in Section 2.5(c) hereto.

COPsync Series B - Investors Rights Agmt (execution).doc

  

  

  

 

(h)           “Initial Closing” means the date of the initial sale of shares of the Company’s Series B Preferred Stock pursuant to the Purchase Agreement.

 

(i)      “Initiating Holders” means any Holder or Holders who in the aggregate hold not less than a majority of the outstanding Registrable Securities.

 

(j)      “New Securities” shall have the meaning set forth in Section 3.1(a) hereto.

 

(k)      “Other Selling Stockholders” means persons other than Holders who, by virtue of agreements with the Company, are entitled to include their Other Shares in certain registrations hereunder.

 

(l)      “Other Shares” means shares of Common Stock, other than Registrable Securities (as defined below), with respect to which registration rights have been granted.

 

(m)           “Purchase Agreement” shall have the meaning set forth in the Recitals hereto.

 

(n)       “Registrable Securities” shall mean (i) shares of Common Stock issued or issuable pursuant to the conversion of the Shares, (ii) shares of Common Stock issued or issuable upon exercise of the Warrants (as defined in the Purchase
Agreement) and (iii) any Common Stock issued as a dividend or other distribution with respect to or in exchange for or in replacement of the shares referenced in (i) or (ii) above; provided, however, that Registrable Securities shall not include any shares of Common Stock described in clause (i), (ii) or (iii) above that have previously been registered or which have been sold to the public either
pursuant to a registration statement or Rule 144 or Rule 145, or which have been sold in a private transaction in which the transferor’s rights under this Agreement are not validly assigned in accordance with this Agreement.

 

(o)      The terms “register,” “registered” and “registration” shall refer to a registration effected by preparing
and filing a registration statement in compliance with the Securities Act and applicable rules and regulations thereunder, and the declaration or ordering of the effectiveness of such registration statement.

 

(p)      “Registration Expenses” shall mean all expenses incurred in effecting any registration pursuant to this Agreement, including, without limitation, all registration, qualification, and filing fees, printing expenses, escrow fees, fees
and disbursements of counsel for the Company and one special counsel for the Holders, blue sky fees and expenses, and expenses of any regular or special audits incident to or required by any such registration, but shall not include Selling Expenses, fees and disbursements of other counsel for the Holders and the compensation of regular employees of the Company, which shall be paid in any event by the Company.

 

(q)      “Restricted Securities” shall mean any Registrable Securities required to bear the legend set forth in Section 2.7(b) hereof.

 

(r)      “Rule 144” means Rule 144 as promulgated by the Commission under the Securities Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission.

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-2-

  

 

(s)           “Rule 145” means Rule 145 as promulgated by the Commission under the Securities Act, as such Rule may be amended from time to time, or any similar successor rule that may be promulgated by the Commission.

 

(t)      “Securities Act” means the Securities Act of 1933, as amended, or any similar successor federal statute and the rules and regulations thereunder, all as the same shall be in effect from time to time.

 

(u)      “Selling Expenses” means all underwriting discounts, selling commissions and stock transfer taxes applicable to the sale of Registrable Securities and fees and disbursements of counsel for any Holder (other than the fees and disbursements
of one special counsel to the Holders included in Registration Expenses).

 

(v)      “Series B Director” shall have meaning given such term in the Company’s Amended and Restated Certificate of Incorporation, as amended from time to time.

 

(w)           “Series B Preferred Stock” means the shares of Series B Preferred Stock issued pursuant to the Purchase Agreement.

 

(x)      “Shares” means the Company’s Series B Preferred Stock.

 

Section 2

 

Registration Rights

 

 

2.1      Requested Registration

 

.

 

(a)      Request for Registration.  Subject to the conditions set forth in this Section 2.1, if the Company shall receive from Initiating Holders a written request signed by such Initiating
Holders that the Company effect any registration with respect to at least a majority of the Registrable Securities (such request shall state the number of shares of Registrable Securities to be disposed of by such Initiating Holders), the Company will:

 

(i)      promptly give written notice of the proposed registration to all other Holders; and

 

(ii)      as soon as practicable, file and use its best efforts to effect such registration (including, without limitation, filing post-effective amendments, appropriate qualifications under applicable blue sky or other state securities laws, and appropriate compliance with the Securities Act) and to permit
or facilitate the sale and distribution of all or such portion of such Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any Holder or Holders joining in such request as are specified in a written request received by the Company within twenty (20) days after such written notice from the Company is mailed or delivered.

 

(b)      Limitations on Requested Registration.  The Company shall not be obligated to effect, or to take any action to effect, any such registration pursuant to this Section 2.1:

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-3-

  

 

(i)           Prior to the two (2) year anniversary of the date of this Agreement;

 

(ii)      In any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, qualification, or compliance, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities
Act;

 

(iii)                 After the Company has initiated one (1) such registration pursuant to this Section 2.1; or

 

(iv)                 During the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of filing of, and ending on a date ninety (90) days after the effective date of, a Company-initiated registration (or
ending on the subsequent date on which all market stand-off agreements applicable to the offering have terminated); provided that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective.

 

(c)      Deferral.  If (i) in the good faith judgment of the Board of Directors of the Company, the filing of a registration statement covering the Registrable Securities would be detrimental
to the Company and the Board of Directors of the Company concludes, as a result, that it is in the best interests of the Company to defer the filing of such registration statement at such time, and (ii) the Company shall furnish to such Holders a certificate signed by the Chief Executive Officer of the Company stating that in the good faith judgment of the Board of Directors of the Company, it would be detrimental to the Company for such registration statement to be filed in the near future and that it is,
therefore, in the best interests of the Company to defer the filing of such registration statement, then (in addition to the limitations set forth in Section 2.1(b)(iv) above) the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders, and, provided further, that the Company shall not defer its obligation in this
manner more than two (2) times in any twelve-month period.

 

(d)      Other Shares.  The registration statement filed pursuant to the request of the Initiating Holders may include Other Shares, and may include securities of the Company being sold for the account of the Company.

 

2.2      Company Registration

 

.

 

(a)      Company Registration. If the Company shall determine to register any of its securities either for its own account or the account of a security holder or holders who is an affiliate of the Company, other than a registration pursuant to Section 2.1,
a registration relating solely to employee benefit plans, a registration relating to the offer and sale of debt securities, a registration relating to a corporate reorganization or other Rule 145 transaction, or a registration on any registration form that does not permit secondary sales, the Company will:

 

(i)      promptly give written notice of the proposed registration to all Holders; and

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-4-

  

 

(ii)           use its commercially reasonable efforts to include in such registration (and any related qualification under blue sky laws or other compliance), except as set forth in Section 2.2(b) below, and in any underwriting involved therein,
all of such Registrable Securities as are specified in a written request or requests made by any Holder or Holders received by the Company within twenty (20) days after such written notice from the Company is delivered to such Holder or Holders.  Such written request may specify all or a part of a Holder’s Registrable Securities.

 

(b)      Underwriting.  If the registration of which the Company gives notice is for a registered public offering involving an underwriting, the Company shall so advise the Holders as a part of the written notice given pursuant to Section 2.2(a)(i).  In
such event, the right of any Holder to registration pursuant to this Section 2.2 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein.  All Holders proposing to distribute their securities through such underwriting must (together with the Company, the Other Selling Stockholders and other holders of securities of the
Company with registration rights to participate therein distributing their securities through such underwriting) enter into an underwriting agreement in customary form with the representative of the underwriter or underwriters selected by the Company.

 

Notwithstanding any other provision of this Section 2.2, if the underwriters advise the Company in writing that marketing factors require a limitation on the number of shares to be underwritten, the underwriters may (subject to the limitations set forth below) limit the number of Registrable Securities
to be included in, the registration and underwriting.  The Company shall so advise all holders of securities requesting registration, and the number of shares of securities that are entitled to be included in the registration and underwriting shall be allocated, as follows: (i) first, to the Company for securities being sold for its own account, (ii) second, to the Holders requesting to include Registrable Securities in such registration statement based on the pro rata percentage of Registrable
Securities held by such Holders, assuming conversion and (iii) third, to the Other Selling Stockholders requesting to include Other Shares in such registration statement based on the pro rata percentage of Other Shares held by such Other Selling Stockholders, assuming conversion. Notwithstanding the foregoing, no such reduction shall reduce the Registrable Securities of the Holders included in such registration, unless such registration does not include shares of any other selling stockholders, in which
event any or all of the Registrable Securities of the Holders may be excluded.

 

If a Holder who has requested inclusion in such registration as provided above does not agree to the terms of any such underwriting, such Holder shall also be excluded therefrom by written notice from the Company or the underwriter.  The Registrable Securities or other securities so excluded shall also be withdrawn from such registration.
Any Registrable Securities or other securities excluded or withdrawn from such underwriting shall be withdrawn from such registration.

 

(c)      Right to Terminate Registration.  The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.2 prior to the effectiveness of such
registration whether or not any Holder has elected to include securities in such registration.

 

2.3      Expenses of Registration

 

.  All Registration Expenses incurred in connection with  registrations pursuant to Sections 2.1 and 2.2 hereof shall be borne by the Company; provided, however,
that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 2.1 if the registration request is

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-5-

  

 

subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered or because a sufficient number of Holders shall have withdrawn so that the minimum offering conditions set forth in Section 2.1 are
no longer satisfied (in which case all participating Holders shall bear such expenses pro rata among each other based on the number of Registrable Securities requested to be so registered), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to a demand registration pursuant to Section 2.1.  All Selling Expenses relating to securities registered on behalf of the Holders shall be borne by the holders of securities included
in such registration pro rata among each other on the basis of the number of Registrable Securities so registered.

 

2.4      Registration Procedures

 

.  In the case of each registration effected by the Company pursuant to Section 2, the Company will keep each Holder advised in writing as to the initiation of each registration and as to the completion thereof.  At its expense, the Company will use its commercially reasonable efforts
to:

 

(a)      Keep such registration effective for a period of ending on the earlier of the date which is sixty (60) days from the effective date of the registration statement or such time as the Holder or Holders have completed the distribution described in the registration statement relating thereto;

 

(b)      Prepare and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered
by such registration statement for the period set forth in subsection (a) above;

 

(c)      Furnish such number of prospectuses, including any preliminary prospectuses,  and other documents incident thereto, including any amendment of or supplement to the prospectus, as a Holder from time to time may reasonably request;

 

(d)      Use its reasonable best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdiction as shall be reasonably requested by the Holders; provided, that the
Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions;

 

(e)      Notify each seller of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in light of the circumstances then existing, and following such notification promptly prepare and furnish to such seller a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such shares, such prospectus shall not include
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in light of the circumstances then existing;

 

(f)      Cause all such Registrable Securities registered pursuant hereunder to be listed on each securities exchange on which similar securities issued by the Company are then listed; and

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-6-

  

 

(g)           In connection with any underwritten offering pursuant to a registration statement filed pursuant to Section 2.1 hereof, enter into an underwriting agreement in form reasonably necessary to effect the offer and sale of Common Stock, provided such
underwriting agreement contains reasonable and customary provisions, and provided further, that each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement.

 

2.5      Indemnification

 

. 

 

(a)      To the extent permitted by law, the Company will indemnify and hold harmless each Holder, each of its officers, directors and partners, legal counsel and accountants and each person controlling such Holder within the meaning of Section 15 of the Securities Act, with respect to which registration,
qualification or compliance has been effected pursuant to this Section 2, and each underwriter, if any, and each person who controls within the meaning of Section 15 of the Securities Act any underwriter, against all expenses, claims, losses, damages and liabilities (or actions, proceedings or settlements in respect thereof) arising out of or based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by reference
in any prospectus, offering circular or other document (including any related registration statement, notification or the like) incident to any such registration, qualification or compliance, (ii) any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) any violation (or alleged violation) by the Company of the Securities Act, any state securities laws or any rule or regulation thereunder applicable
to the Company and relating to action or inaction required of the Company in connection with any offering covered by such registration, qualification or compliance, and the Company will reimburse, as incurred, each such Holder, each of its officers, directors, partners, legal counsel and accountants and each person controlling such Holder, each such underwriter and each person who controls any such underwriter, for any legal and any other expenses reasonably incurred in connection with investigating and defending
or settling any such claim, loss, damage, liability or action; provided that the Company will not be liable in any such case to the extent that any such claim, loss, damage, liability, or action arises out of or is based on any untrue statement or omission based solely upon information furnished to the Company by such Holder, any of such Holder’s officers, directors, partners, legal counsel or accountants, any person controlling such Holder, such
underwriter or any person who controls any such underwriter, in writing, and stated to be specifically for use therein; and provided, further that, the indemnity agreement contained in this Section 2.5(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent
of the Company (which consent shall not be unreasonably withheld); provided further, however, that the foregoing indemnity agreement with respect to any preliminary prospectus shall not inure to the benefit of any Holder, officer, director, partner, legal counsel, accountant, or any person controlling such Holder, from whom the person asserting any such losses, claims, damages or liabilities purchased shares in the offering, if a copy of the prospectus
(as then amended or supplemented if the Company shall have furnished any amendments or supplements thereto) was not sent or given by or on behalf of such Holder to such person, if required by law so to have been delivered, at or prior to the written confirmation of the sale of the shares to such person, and the untrue statement or alleged untrue statement or omission or alleged omission of a material fact contained in such preliminary prospectus was corrected in the final prospectus (as so amended or supplemented).

 

(b)      To the extent permitted by law, each Holder will, if Registrable Securities held by such Holder are included in the securities as to which such registration, qualification or compliance is being

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-7-

  

 

effected, indemnify and hold harmless the Company, each of its directors, officers, partners, legal counsel and accountants and each underwriter, if any, of the Company’s securities covered by such a registration statement, each person who controls the Company or such underwriter within the meaning of Section 15 of the Securities
Act, each other such Holder, and each of their officers, directors and partners, and each person controlling each other such Holder, against all claims, losses, damages and liabilities (or actions in respect thereof) arising out of or based on: (i) any untrue statement (or alleged untrue statement) of a material fact contained or incorporated by reference in any prospectus, offering circular or other document (including any related registration statement, notification, or the like) incident to any such registration,
qualification or compliance, or (ii) any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse, as incurred, the Company and such Holders, directors, officers, partners, legal counsel and accountants, persons, underwriters, or control persons for any legal or any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability or action,
in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering circular or other document in reliance upon and in conformity with information furnished to the Company by such Holder in writing and stated to be specifically for use therein; provided, however,
that the obligations of such Holder hereunder shall not apply to amounts paid in settlement of any such claims, losses, damages or liabilities (or actions in respect thereof) if such settlement is effected without the consent of such Holder (which consent shall not be unreasonably withheld); and provided that in no event shall any indemnity under this Section 2.5 exceed the gross proceeds from the offering received
by such Holder, except in the case of fraud or willful misconduct by such Holder.

 

(c)      Each party entitled to indemnification under this Section 2.5 (the “Indemnified Party”)
shall give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall permit the Indemnifying Party to assume the defense of such claim or any litigation resulting therefrom; provided that
counsel for the Indemnifying Party, who shall conduct the defense of such claim or any litigation resulting therefrom, shall be approved by the Indemnified Party (whose approval shall not be unreasonably withheld), and the Indemnified Party may participate in such defense at such party’s expense, unless:  (1) the Indemnifying Party has agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to assume the defense of such claim and to employ counsel
reasonably satisfactory to such Indemnified Party; or (3) the named parties to any proceeding relating to such claim (including any impleaded parties) include both the Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent the Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects
to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party); and provided further that the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying
Party of its obligations under this Section 2.5, to the extent such failure is not prejudicial.  No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such
claim or litigation.  Each Indemnified Party shall furnish such information regarding itself or the claim in question as an Indemnifying Party may reasonably request in writing and as shall be reasonably required in connection with defense of such claim and litigation resulting therefrom.

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-8-

  

 

(d)           If the indemnification provided for in this Section 2.5 is held by a court of competent jurisdiction to be unavailable to an Indemnified Party with respect to any loss, liability, claim, damage, or expense referred to herein,
then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified Party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage, or expense as well as any other relevant
equitable considerations.  The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission.  No
person or entity will be required under this Section 2.5(d) to contribute any amount in excess of the gross proceeds from the offering received by such person or entity, except in the case of fraud or willful misconduct by such person or entity.  No person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty of such fraudulent
misrepresentation.

 

(e)      Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall
control.

 

2.6      Information by Holder

 

.  Each Holder of Registrable Securities shall furnish to the Company such information regarding such Holder and the distribution proposed by such Holder as the Company may reasonably request in writing and as shall be reasonably required in connection with any registration, qualification, or compliance referred to in this Section 2.

 

2.7      Restrictions on Transfer

 

.

 

(a)      The holder of each certificate representing Registrable Securities by acceptance thereof agrees to comply with the provisions of this Section 2.7.  Each Holder agrees not to make any sale, assignment, transfer, pledge or other disposition of all
or any portion of the Restricted Securities, or any beneficial interest therein, unless and until:

 

(i)      There is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is made in accordance with such registration statement; or

 

(ii)      Such Holder shall have given prior written notice to the Company of such Holder’s intention to make such disposition and shall have furnished the Company with a detailed description of the manner and circumstances of the proposed disposition, and, if requested by the Company, such Holder shall
have furnished the Company, at the Company’s reasonable expense, with (i) an opinion of counsel, reasonably satisfactory to the Company, to the effect that such disposition will not require registration of such

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-9-

  

 

Restricted Securities under the Securities Act or (ii) a “no action” letter from the Commission to the effect that the transfer of such securities without registration will not result in a recommendation by the staff of the Commission that action be taken with respect thereto, whereupon the holder of such Restricted Securities
shall be entitled to transfer such Restricted Securities in accordance with the terms of the notice delivered by the Holder to the Company.

 

(b)      Each certificate representing Registrable Securities shall (unless otherwise permitted by the provisions of this Agreement) be stamped or otherwise imprinted with a legend substantially similar to the following (in addition to any legend required under applicable state securities laws):

 

THE SECURITIES REPRESENTED BY HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE WITH THE REQUIREMENTS OF SUCH ACT AND THE APPLICABLE SECURITIES
LAW OF ANY STATE OR OTHER JURISDICTION.

 

The Holders consent to the Company making a notation on its records and giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer established in this Section 2.7.

 

(c)      The legend identified in Section 2.7(b) hereof stamped on a certificate evidencing the Restricted Securities and the stock transfer instructions and record notations with respect to such Restricted Securities shall be removed and the Company shall issue a
certificate without such legend to the holder of such Restricted Securities if (i) such securities are registered under the Securities Act, or (ii) such holder provides the Company, at the Company’s reasonable expense, with an opinion of counsel reasonably acceptable to the Company to the effect that a public sale or transfer of such securities may be made without registration under the Securities Act.

 

2.8      Rule 144 Reporting

 

.  With a view to making available the benefits of certain rules and regulations of the Commission that may permit the sale of the Restricted Securities to the public without registration, the Company agrees to use its commercially reasonable efforts to:

 

(a)      Make and keep public information regarding the Company available as those terms are understood and defined in Rule 144 under the Securities Act; and

 

(b)      File with the Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act.

 

2.9      Delay of Registration

 

.  No Holder shall have any right to take any action to restrain, enjoin, or otherwise delay any registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2.

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-10-

  

 

2.10           Transfer or Assignment of Registration Rights

 

.  The rights to cause the Company to register securities granted to a Holder by the Company under this Section 2 may be transferred or assigned by a Holder to a transferee or assignee; provided that (i) such transfer or assignment
of Registrable Securities is effected in accordance with the terms of Section 2.7 hereof and applicable securities laws, (ii) the Company is given written notice prior to said transfer or assignment, stating the name and address of the transferee or assignee and identifying the securities with respect to which such registration rights are intended to be transferred or assigned and (iii) the transferee or assignee of such rights assumes in writing the obligations
of such Holder under this Agreement.

 

2.11           Termination of Registration Rights

 

.  The right of any Holder to request registration or inclusion in any registration pursuant to Sections 2.1 or 2.2 shall terminate on such date on which all shares of Registrable Securities
held or entitled to be held by such Holder may immediately be sold under Rule 144 or Rule 145.

 

Section 3

 

Right of First Refusal

 

3.1      Right of First Refusal

 

.  The Company hereby grants to the Holders of Registrable Securities the right of first refusal to purchase all, but not less than all, of New Securities (as defined in this Section 3.1(a)) which the Company may, from time to time, propose to sell and issue after the date of this Agreement.  This
right of first refusal shall be subject to the following provisions:

 

(a)      “New Securities” shall mean any capital stock (including Common Stock and/or Preferred Stock) of the Company whether now authorized or not, and rights, convertible securities, options or warrants to purchase such capital stock, and securities
of any type whatsoever that are, or may become, exercisable or convertible into capital stock; provided that the Company is proposing to sell and issue the New Securities in a transaction, or series of related transactions, in which the Company will receive $2,000,000 or more in gross proceeds and the investors in such transaction require that the Series B Preferred Stock be converted as a condition to such investment.

 

(b)      In the event the Company proposes to undertake an issuance of New Securities, it shall give each Holder written notice of its intention, describing the type of New Securities, and their price and the general terms upon which the Company proposes to issue the same.  The Holders shall have fifteen
(15) business days after any such notice is delivered to the Holders to agree to purchase all, but not less than all, of such New Securities for the price and upon the terms specified in the notice by giving written notice to the Company.

 

(c)      In the event the Holders fail to exercise fully the right of first refusal rights within said fifteen (15) day period (the “Election Period”), the Company shall have ninety (90)
days thereafter to sell or enter into an agreement (pursuant to which the sale of New Securities covered thereby shall be closed, if at all, within ninety (90) days from the date of said agreement) to sell the New Securities, at a price and upon terms no more favorable to the purchasers thereof than specified in the Company’s notice to Holders delivered pursuant to Section 3.1(b).  In the event the Company has not sold within such ninety (90) day period
following the Election Period, or such ninety (90) day period following the date of said agreement, the

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-11-

  

 

Company shall not thereafter issue or sell any New Securities, without first again offering such securities to the Holders in the manner provided in this Section 3.1.

 

3.2      Termination of Right of First Refusal.

 

  The right of first refusal granted under this Agreement shall expire upon, and shall not be applicable upon the conversion of all of the outstanding shares the Series B Preferred Stock into Common Stock.

 

Section 4

 

Additional Covenants

 

4.1      Matters Requiring Board Approval

 

.  The Company hereby covenants and agrees with each of the Investors that it shall not, without unanimous approval of the Board of Directors of the Company, use any of the proceeds from the sale of the Shares to (i) pay back compensation or benefits of employee directors, or (ii) pay any service provider or vendor who is a stockholder,
director or employee of the Company, or a relative or other affiliate of such person.

 

4.2      Monthly Board Meetings

 

.  Unless otherwise determined by the unanimous vote of the directors then in office, the Board of Directors of the Company shall meet at least monthly in accordance with an agreed-upon schedule.  Such meetings may be attended telephonically.

 

4.3      Board Expenses and Indemnification

 

.  The Company shall reimburse the non-employee directors for all reasonable out-of-pocket travel expenses incurred (consistent with the Company’s travel policy) in connection with attending meetings of the Board of Directors, if the Chairman of the Board of Directors requests the physical presence of all directors at such meeting.  The
Company will indemnify the members of the Board of Directors of the Company to the fullest extent allowed the Delaware General Corporation Law.  As soon as practicable after the date of this Agreement, but not later than thirty (30) days after the date of this Agreement, the Company shall obtain and maintain a policy or policies of director and officer liability insurance with reputable insurance companies providing the officers and directors of the Company with coverage for losses from wrongful acts,
or to ensure the Company’s performance of its indemnification obligations, which policy or policies shall be reasonably acceptable to the Series B Director.

 

4.4      Patent Rights

 

.  The Company shall, as soon as reasonably practicable, but not later than ten (10) days after the date of this Agreement, engage patent counsel to undertake and complete a patentability assessment with respect to the Company Products (as defined in the Purchase Agreement), including specifically, but without limitation, the Company’s
current primary Company Product, and, unless such assessment determines that none of the Company Products or any of their elements are patentable, the Company shall, prior to December 8, 2009, cause to be prepared and filed by such patent counsel at the United States Patent and Trademark Office one or more U.S. non-provisional patent applications directed to and claiming said Company Products that are determined by such assessment to be patentable; provided, however,
that the Company will not be required to

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-12-

  

 

make any such filing if, after discussions with such patent counsel, the Company’s determines, in its reasonable judgment, that such filing is not in the best interests of the Company.

 

4.5      Termination of Additional Covenants

 

.  The covenants set forth in this Section 5 shall terminate and be of no further force or effect upon the earlier of (i) the conversion of all outstanding shares of the Series B Preferred Stock into Common Stock; or (ii) a Change of Control Transaction in which the Series B Preferred Stock are entitled to a distribution in any liquidation
or deemed liquidation.  “Change of Control Transaction” means either (i) the acquisition of the Company by another entity by means of any transaction or series of related transactions to which the Company is party (including, without limitation, any stock acquisition, reorganization, merger or consolidation but excluding any sale of stock for capital raising purposes) other
than a transaction or series of transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction retain, immediately after such transaction or series of transactions, as a result of shares in the Company held by such holders prior to such transaction, at least a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity (or if the Company or such other surviving or resulting
entity is a wholly-owned subsidiary immediately following such acquisition, its parent); (ii) a sale, lease or other disposition of all or substantially all of the assets of the Company and its subsidiaries taken as a whole by means of any transaction or series of related transactions, except where such sale, lease or other disposition is to a wholly-owned subsidiary of the Company; (iii) an exclusive license of all or substantially all of the Company’s intellectual property in a single transaction
or series of related transaction, except where such exclusive license is to a wholly-owned subsidiary of the Company; or (iv) any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary.

 

Section 5

 

Miscellaneous

 

5.1      Amendment

 

.  Except as expressly provided herein, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument referencing this Agreement and signed by the Company and the Holders holding at least a majority of the Registrable Securities (excluding any of such shares that have been
sold to the public or pursuant to Rule 144).  Any such amendment, waiver, discharge or termination effected in accordance with this paragraph shall be binding upon each Holder and each future holder of all such securities of Holder.  Each Holder acknowledges that by the operation of this paragraph, the holders of a majority of the Registrable Securities (excluding any of such shares that have been sold to the public or pursuant to Rule 144) will have the right and power to diminish
or eliminate all rights of such Holder under this Agreement.

 

5.2      Notices

 

.  All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or electronic mail or otherwise delivered by hand or by messenger addressed:

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-13-

  

 

(a)           if to an Investor, at the Investor’s address, facsimile number or electronic mail address as shown in the Company’s records, as may be updated in accordance with the provisions hereof;

 

(b)      if to any Holder, at such address, facsimile number or electronic mail address as shown in the Company’s records, or, until any such holder so furnishes an address, facsimile number or electronic mail address to the Company, then to and at the address, facsimile number or electronic mail address
of the last holder of such shares for which the Company has contact information in its records; or

 

(c)      if to the Company, one copy should be sent to 2010 FM 2673, Canyon Lake, Texas 78133, facsimile: (830) 964-3873, Attn: Chief Executive Officer, or at such other address as the Company shall have furnished to the Investors, with a copy to J. William Wilson, Phillips & Reiter, PLLC, 6805 Capital of
Texas Highway North, Suite 318, Austin, Texas 78731.

 

With respect to any notice given by the Company under any provision of the Delaware General Corporation Law or the Company’s charter or bylaws, each party hereto agrees that such notice may be given by facsimile or by electronic mail.

 

Each such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given when delivered if delivered personally, or, if sent by mail, at the earlier of its receipt or 72 hours after the same has been deposited in a regularly maintained receptacle for the deposit of the United States
mail, addressed and mailed as aforesaid or, if sent by facsimile, upon confirmation of facsimile transfer or, if sent by electronic mail, upon confirmation of delivery when directed to the electronic mail address set forth on the Schedule of Investors. In the event of any conflict between the Company’s books and records and this Agreement or any notice delivered hereunder, the Company’s books and records will control absent fraud or error.

 

5.3      Governing Law

 

.  This Agreement shall be governed in all respects by the internal laws of the State of Delaware as applied to agreements entered into among Delaware residents to be performed entirely within Delaware, without regard to principles of conflicts of law.

 

5.4      Successors and Assigns

 

.  This Agreement, and any and all rights, duties and obligations hereunder, shall not be assigned, transferred, delegated or sublicensed by any Investor without the prior written consent of the Company.  Any attempt by an Investor without such permission to assign, transfer, delegate or sublicense any rights, duties or obligations
that arise under this Agreement shall be void.  Subject to the foregoing and except as otherwise provided herein, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

 

5.5      Entire Agreement

 

.  This Agreement and the exhibits hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof.  No party hereto shall be liable or bound to any other party in any manner with regard to the subjects hereof or thereof by any warranties, representations or covenants
except as specifically set forth herein.

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-14-

  

 

5.6           Delays or Omissions

 

.  Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing to any party to this Agreement upon any breach or default of any other party under this Agreement shall impair any such right, power or remedy of such non-defaulting party, nor shall it be construed to be a waiver of any such
breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring.  Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall
be effective only to the extent specifically set forth in such writing.  All remedies, either under this Agreement or by law or otherwise afforded to any party to this Agreement, shall be cumulative and not alternative.

 

5.7      Severability

 

.  If any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Agreement, and such court will replace such illegal, void or unenforceable provision
of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the same economic, business and other purposes of the illegal, void or unenforceable provision.  The balance of this Agreement shall be enforceable in accordance with its terms.

 

5.8      Titles and Subtitles

 

.  The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.  All references in this Agreement to sections, paragraphs and exhibits shall, unless otherwise provided, refer to sections and paragraphs hereof and exhibits attached hereto.

 

5.9      Counterparts

 

.  This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the parties that execute such counterparts, and all of which together shall constitute one instrument.

 

5.10           Telecopy Execution and Delivery

 

.  A facsimile, telecopy or other reproduction of this Agreement may be executed by one or more parties hereto and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the signature of or on behalf of such party can be seen.  Such execution and delivery shall be considered valid,
binding and effective for all purposes.  At the request of any party hereto, all parties hereto agree to execute and deliver an original of this Agreement as well as any facsimile, telecopy or other reproduction hereof.

 

5.11           Jurisdiction; Venue

 

.  Any action, suit or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby shall only be brought in any federal court or state court located in the State of Texas, and each party consents to the exclusive

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-15-

  

 

jurisdiction and venue of such courts (and of the appropriate appellate courts therefrom) in any such action, suit or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such, action, suit or proceeding in any such court or that any such
action, suit or proceeding brought in any such court has been brought in an inconvenient forum.  Process in any such action, suit or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court.

 

5.12           Further Assurances

 

.  Each party hereto agrees to execute and deliver, by the proper exercise of its corporate, limited liability company, partnership or other powers, all such other and additional instruments and documents and do all such other acts and things as may be necessary to more fully effectuate this Agreement.

 

5.13           Termination Upon Change of Control

 

.  Notwithstanding anything to the contrary herein, this Agreement (excluding any then-existing obligations) shall terminate upon a Change of Control Transaction in which the Series B Preferred Stock are entitled to a distribution in any liquidation or deemed liquidation.

 

5.14           Conflict

 

.  In the event of any conflict between the terms of this Agreement and the Company’s Certificate of Incorporation or its Bylaws, the terms of the Company’s Certificate of Incorporation or its Bylaws, as the case may be, will control.

 

5.15           Aggregation of Stock

 

.  All securities held or acquired by affiliated entities (including affiliated venture capital funds) or persons shall be aggregated together for purposes of determining the availability of any rights under this Agreement.

 

(Remainder of page intentionally left blank)

COPsync Series B - Investors Rights Agmt (execution).doc --

  

-16-

  

 

IN WITNESS WHEREOF, the parties hereto have executed this Investors’ Rights Agreement effective as of the day and year first above written.

 

COPSYNC, INC.

a Delaware corporation

 

By:                                                                    

Russell D. Chaney,

Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}]]